US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Diagnostics Company Reports Market Research Reports & Industry Analysis

RSS Feeds

Diagnostics Company Reports Industry Research & Market Reports

4  5  6  7    9    11  12  13  
Response Biomedical Corporation (RBM) - Financial and Strategic SWOT Analysis Review
8/5/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
SomaLogic, Inc. - Product Pipeline Analysis, 2014 Update
8/6/2014 | published by: GlobalData
... are used in clinical diagnosis of EDTA plasma, citrate plasma, serum, CSF, tissue homogenate, cell lysates and conditioned cell media. The company's SomaSuite is a software solution that provides access to the highly multiplexed proteomic ...  |  read more...
USD 750
TrovaGene, Inc. (TROV) - Product Pipeline Analysis, 2014 Update
8/6/2014 | published by: GlobalData
... tests are used in detection of transrenal DNA (TrDNA) and RNA (TrRNA). The technology is used in tumor detection and monitoring, prenatal genetic testing, infectious diseases, tissue transplantation, forensic identification, and for patient selection in ...  |  read more...
USD 750
Venaxis, Inc. (APPY) - Financial and Strategic SWOT Analysis Review
8/5/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
XEPTAGEN SpA - Product Pipeline Analysis, 2014 Update
8/13/2014 | published by: GlobalData
... COLONIC, HEPA AB, HEPA IC, PROSTATEIC and SCCALISA. The company develops an optoelectronic biochip for the determination of tumor molecular markers. It conducts research on developing biochips for the simultaneous detection of biomarkers-IgM immunecomplexes. The ...  |  read more...
USD 750
Exosome Diagnostics, Inc. - Product Pipeline Analysis, 2014 Update
8/6/2014 | published by: GlobalData
... for plasma, EXO60 kit for cerebro spinal fluid, and EXO70 kit for urine. The company provides miRNA profiling, mRNA profiling, mutation detection, and custom assay development services. The company’s technology is used in the treatment ...  |  read more...
USD 750
Healthcare News - Vital Signs - The Analyst's Perspective - April Issue
4/30/2014 | published by: Frost & Sullivan
... brewing in the pharma/biotech industry, Pfizer Inc’s Xalkori for non-small cell lung cancer, Novartis' halt on RNAi development efforts, the high-ranked Malaysian healthcare system, Roche's acquisition of IQuum's Liat Analyzer, and Bio-Rad's acquisition of GnuBio.  |  read more...
USD 450
Exact Sciences Corporation (EXAS) - Financial and Strategic SWOT Analysis Review
4/29/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
GE Healthcare - Strategic SWOT Analysis Review
5/15/2014 | published by: GlobalData
... key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope Business description ...  |  read more...
USD 125
Idexx Laboratories, Inc. (IDXX) - Financial and Strategic SWOT Analysis Review
5/15/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
IMRIS Inc. (IM) - Financial and Strategic SWOT Analysis Review
5/15/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Laboratory Corporation of America Holdings (LH) - Financial and Strategic SWOT Analysis Review
4/29/2014 | published by: GlobalData
... bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you ...  |  read more...
USD 125
Myriad Genetics, Inc. (MYGN) - Product Pipeline Analysis, 2014 Update
5/16/2014 | published by: GlobalData
... through the treatment decisions. Its product portfolio iincludes nine commercial molecular diagnostic tests, namely, six predictive medicine tests; one prognostic medicine test; and two personalized medicine tests in the areas of oncology and CNS related ...  |  read more...
USD 750
OncoVista Innovative Therapies, Inc. (OVIT) - Financial and Strategic SWOT Analysis Review
5/15/2014 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
Roche Diagnostics Limited - Product Pipeline Analysis, 2014 Update
5/14/2014 | published by: GlobalData
... for the in-vitro and virology markets. The company provides services to individuals and health professionals to facilitate the detection, monitoring, and management of their patients' medical conditions. It offers its products and services to patients, ...  |  read more...
USD 750
Waters Corporation (WAT) - Financial and Strategic SWOT Analysis Review
5/15/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Insight Genetics, Inc. - Product Pipeline Analysis, 2014 Update
5/16/2014 | published by: GlobalData
... Genetics, through its lab provides cancer testing services mainly to oncologists and pharmaceutical companies. The pipeline portfolio of the company includes ROS1, RET and DEPDC1 for lung cancer and ALK ECD for breast cancer. The ...  |  read more...
USD 750
Alliance Healthcare Services, Inc. (AIQ) - Financial and Strategic SWOT Analysis Review
5/21/2014 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
bioMerieux S.A. (BIM) - Product Pipeline Analysis, 2014 Update
6/6/2014 | published by: GlobalData
... namely, Clinical Applications and Industrial Applications. The company offers diagnostic solutions such as instruments, reagents and software. bioMerieux products are used in diagnosing infectious diseases and provide high medical value results in cancer screening and ...  |  read more...
USD 750
Cepheid (CPHD) - Financial and Strategic SWOT Analysis Review
5/21/2014 | published by: GlobalData
... clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, ...  |  read more...
USD 125
Cepheid (CPHD) - Product Pipeline Analysis, 2014 Update
6/6/2014 | published by: GlobalData
... include IVD medical devices, CE marked products, and research use only tests in the areas of healthcare associated infections, critical infectious disease, sexual health, women’s health, virology, oncology and genetics. Cepheid’s two major systems include ...  |  read more...
USD 750
Lantheus Medical Imaging, Inc. - Strategic SWOT Analysis Review
5/20/2014 | published by: GlobalData
... key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope ...  |  read more...
USD 125
Primary Health Care Ltd (PRY) - Financial and Strategic SWOT Analysis Review
5/21/2014 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
Qiagen N.V. (QIA) - Product Pipeline Analysis, 2014 Update
6/6/2014 | published by: GlobalData
... and sample and assay technologies to study the molecular information of biological material. Its sample technologies help isolate and process proteins, DNA and RNA from biological samples such as blood or tissueand assay technologies facilitate ...  |  read more...
USD 750
VCA Antech, Inc. (WOOF) - Financial and Strategic SWOT Analysis Review
6/4/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
4  5  6  7    9    11  12  13